Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DUBLIN, Ireland, Jan. 16, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR) and Novo Nordisk A/S (NYSE:NVO), a world leader in diabetes, have entered into a Development and License Agreement...
-
DUBLIN, Ireland, Jan. 16, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR) and Novo Nordisk A/S (NYSE:NVO), a world leader in diabetes, have entered into a Development and License...
-
DUBLIN, Ireland, Nov. 24, 2008 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR)and Novo Nordisk A/S (NYSE:NVO), a world leader in diabetes, have entered into a Development and License Agreement...
-
DUBLIN, Ireland, Nov. 5, 2008 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR), an international specialty pharmaceutical company, today announced that it has been awarded the Frost &...
-
DUBLIN, Ireland, July 18, 2008 (PRIME NEWSWIRE) -- Merrion Pharmaceuticals today announced the continuation of an oral drug delivery research collaboration programme with Novo Nordisk. This follows on...